Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 69
Filtrar
1.
Physiol Res ; 68(Suppl 4): S475-S481, 2019 12 30.
Artigo em Inglês | MEDLINE | ID: mdl-32118479

RESUMO

Based on their field of application, the physical parameters of shock waves differ. Experiments referred to in this article used tandem shock waves generated on the surface of a composite anode. There, individual pores of the anode produce multichannel discharges. The composite anode may have a variety of shapes, which, consequently, influence the arrangement of the entire apparatus and the area of their application. Experiments referred to in this article utilise an anode divided into two parts that generated tandem shock waves. The previously conducted experiments have clearly shown that the effect of a tandem shock wave can be very well localized in the focal area, causing necrosis and apoptosis of the tumor cells, and enhancing the effect of cytostatics. This study investigated the effect of tandem shock waves with concomitantly administered cytostatics. We conducted our experiments on Lewis rats. The rats were injected with syngeneic sarcoma tumor cells intradermally and caudally on both the right and left sides. The highest rate of tumor growth inhibition was observed in the cisplatin-treated group that was subsequently treated with shock waves. The effect of shock waves on cell membranes is well described as they increase their permeability due to sonodynamic effect induced by cavitation. The results of experiments referred to in this article conducted in vivo in experimental animals enable us to note that the shock wave increases the effect of chemotherapy administered.


Assuntos
Antineoplásicos/uso terapêutico , Cisplatino/uso terapêutico , Tratamento por Ondas de Choque Extracorpóreas , Sarcoma/terapia , Animais , Terapia Combinada , Ratos Endogâmicos Lew
2.
Cell Death Dis ; 7: e2048, 2016 Jan 14.
Artigo em Inglês | MEDLINE | ID: mdl-26775700

RESUMO

Survivin, an important antiapoptotic protein, is expressed in tumors, whereas in normal tissues the expression of this protein is extremely low, defining a role for survivin as a cancer gene. Survivin exhibits multifunctional activity in tumor cells. However, why survivin expression is sharply and invariably restricted to tumor tissue remains unclear. Here, we identified 11 putative consensus binding sites for GLI transcription factors in the survivin promoter and characterized the promoter activity. Inhibitors of the Hedgehog/GLI pathway, cyclopamine and GANT61, decreased the promoter activity in reporter assays. ΔNGLI2 (which lacks the repressor domain) was the most potent vector in activating the survivin promoter-reporter. Moreover, GANT61, a GLI1/2 inhibitor, repressed endogenous survivin protein and mRNA expression in most cells across a large panel of tumor cell lines. Chromatin immunoprecipitation showed GLI2 binding to the survivin promoter. The ectopic GLI2-evoked expression of endogenous survivin was observed in normal human fibroblasts. GANT61 decreased survivin level in nude mice tumors, mimicking the activity of GANT61 in cultured cells. The immunohistochemistry and double immunofluorescence of human tumors revealed a correlation between the tissue regions showing high GLI2 and survivin positivity. Thus, these results demonstrated that survivin is a classical transcriptional target of GLI2, a Hedgehog pathway signaling effector. This potentially reflects the high expression of survivin in human tumor cells. As the Hedgehog pathway is upregulated in virtually all types of cancer cells, these findings substantially contribute to the explanation of uniform survivin expression in tumors as a potential target for the development of a more effective treatment of cancers through the inhibition of GLI2 to restrain survivin activity.


Assuntos
Proteínas Hedgehog/metabolismo , Proteínas Inibidoras de Apoptose/genética , Proteínas Inibidoras de Apoptose/metabolismo , Proteínas Repressoras/genética , Proteínas Repressoras/metabolismo , Animais , Humanos , Camundongos , Camundongos Nus , Transdução de Sinais , Survivina , Transfecção
3.
Chembiochem ; 16(4): 555-8, 2015 Mar 02.
Artigo em Inglês | MEDLINE | ID: mdl-25630657

RESUMO

A novel pentamethinium salt was synthesized with an unforeseen expanded conjugated quinoxaline unit directly incorporated into a pentamethinium chain. The compound exhibited high fluorescence intensity, selective mitochondrial localization, high cytotoxicity, and selectivity toward malignant cell lines, and resulted in remarkable in vivo suppression of tumor growth in mice.


Assuntos
Antineoplásicos/química , Hexametônio/química , Neoplasias/tratamento farmacológico , Quinoxalinas/química , Animais , Antineoplásicos/uso terapêutico , Linhagem Celular Tumoral , Ciclização , Hexametônio/uso terapêutico , Camundongos , Neoplasias/patologia , Quinoxalinas/uso terapêutico
4.
Bratisl Lek Listy ; 113(6): 335-8, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22693967

RESUMO

OBJECTIVES: The shock wave is used for the treatment of kidney stones, eventually of gall stones, for more than 20 years. It is a pressure wave, which breaks through soft tissues easily and it is possible to focus it into a small volume. The excellent results of the treatment of concrements led to considerations about another usage of the shock wave. The research is now concentrated on the possibility of the damage to tumour tissues. METHODS: In contrast to concrements tumour tissues are not different from healthy tissues as for their acoustic attributes. That is why a new source of shock waves was used in this work. The source allows generating two successive shock waves focused into a common focus, so-called tandem shock waves. The biological effects of the tandem shock waves generated by the new source on rats hepatic tissue and rabbit femoral muscle in vivo were studied in this work. The damage is demonstrated by magnetic resonance imaging. RESULTS: MR images showed tissue damage in focus. There was damage of the liver tissue, muscle and also stomach wall. CONCLUSIONS: We found that the tandem shock waves are able to damage the acoustically homogeneous soft tissue in the focus, i.e. in the depth. In tissues in front of the focus, there is, however, no damage (Fig. 10, Ref. 15).


Assuntos
Ondas de Choque de Alta Energia/efeitos adversos , Fígado/patologia , Imageamento por Ressonância Magnética , Músculo Esquelético/patologia , Estômago/patologia , Animais , Membro Posterior , Masculino , Coelhos , Ratos , Ratos Wistar
5.
Folia Biol (Praha) ; 58(2): 81-6, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22578959

RESUMO

Proteinase-activated receptor 2 (PAR-2) is a ubiquitous surface molecule. It belongs to the family of G protein-coupled receptors activated by site-specific proteolysis by trypsin. Altered function of PAR-2 has been described in different malignant tumours, both in vivo and in vitro. In the present study, we investigated differences of metastatic spread of B16 melanoma in knock-out animals compared with C57Bl6 mice. Knock-out mice B6.Cg-F2rl1(tm1Mslb)/J (PAR2-/-) and C57Bl6 controls were subcutaneously inoculated with the B16 melanoma tissue cell line. Fourteen days after inoculation, all primary tumours were removed and histopathologically analysed. After one month, animals in both group started to die. Autopsy showed metastatic spread of the melanoma to various organs in both groups. Our experiment confirmed growth and metastatic spread in both groups of mice. Excised tumours differed in volume and weight; average weight (0.62 g in PAR2-/- and 0.4 g in control animals). Metastatic spread was observed in both groups and reached 80 % in PAR2-/- and 50 % in control animals. While in control mice only lung metastases were observed, local tumour recurrence, renal and lung metastases were observed in PAR2-/- mice. The absence of functional PAR-2 could be an important factor influencing the growth and spread of melanoma in vivo, probably associated with tumour cell migration, invasiveness and metastasis formation.


Assuntos
Receptor PAR-2/genética , Receptor PAR-2/fisiologia , Animais , Linhagem Celular Tumoral , Movimento Celular , Masculino , Melanoma Experimental/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Camundongos Transgênicos , Invasividade Neoplásica , Metástase Neoplásica , Transplante de Neoplasias , Pigmentação , Projetos Piloto , Neoplasias Cutâneas/metabolismo
6.
Folia Biol (Praha) ; 57(6): 255-60, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-22264720

RESUMO

Shock waves, pressure waves manifested as a sharp increase in positive pressure followed by a decrease and the negative part of the wave, are not only used to treat concrements in medicine. Recently, research has been focused on the possibility of their use for damaging the tumour tissue. In contrast to concrements, which are different from the surrounding tissue by their acoustic impedance, the tumour tissue has the same acoustic impedance as the surrounding soft tissue. Therefore, we have developed a new source of shock waves, which is based on the principle of multichannel discharge. This new source generates two successive shock waves (tandem shock waves). The first shock creates acoustic non-homogeneity and cavitations in the tissue, and the second shock is damped in it. In this work we demonstrated the effect of tandem shock waves on the muscle tissue in depth. The damage is shown on the images from the magnetic resonance imaging and histological sections. In the further part of the experiment, we investigated the in vivo effects of tandem shock waves in combination with Photosan and cisplatin on the tumour tissue. The application of tandem shock waves resulted in the inhibition of tumour growth, compared with controls, in both parts of the experiment. The largest inhibition effect was observed in the groups of tandem shock waves combined with Photosan and in the second part with cisplatin.


Assuntos
Citostáticos/farmacologia , Ondas de Choque de Alta Energia , Neoplasias/patologia , Fármacos Fotossensibilizantes/farmacologia , Animais , Animais não Endogâmicos , Proliferação de Células/efeitos dos fármacos , Cisplatino/administração & dosagem , Cisplatino/farmacologia , Terapia Combinada , Imageamento por Ressonância Magnética , Músculos/efeitos dos fármacos , Músculos/patologia , Coelhos , Ratos , Ratos Endogâmicos Lew , Tela Subcutânea/efeitos dos fármacos , Tela Subcutânea/patologia , Carga Tumoral/efeitos dos fármacos
7.
Neoplasma ; 57(4): 339-48, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20429625

RESUMO

Nuclease from tomato (TBN1) was produced by in planta biotechnology purified and tested for its anticarcinogenic properties. The nuclease was cytostatic after its intratumoral administration to nude mice bearing human melanoma or prostate carcinoma or after tumor targeting by TBN1 administration intravenously as conjugate with polyethylene glycol (PEG). Inhibitory effects of TBN1 on tumor growth were comparable to effects of bovine seminal RNase (BS-RNase), but the inhibition was reached at about ten times lower protein concentration. Simultaneously, TBN1 exhibited a lower degree of embryotoxicity compared to BS-RNAse and other nucleases. TBN1 showed significant stability in vivo, because it was readily detected after its administration intratumorally or intravenously by the fluorescence methods. Intravenous administration of TBN1-PEG caused significant inhibition of tumor proliferation without obvious degenerative changes, while direct administration of TBN1 into melanoma tumors led to rapid tumor tissue degeneration. The fact can be essential for the mode of TBN1 biological action that mature nuclease is a small (36 kDa) thermostable glycoprotein that has ability to destroy human 28S, 18S, 7S and 5.8S RNA, circular RNAs, double-stranded RNA in vitro and shows DNase and 3'nucleotidase activities.


Assuntos
Antineoplásicos/farmacologia , Apoptose/efeitos dos fármacos , Endodesoxirribonucleases/farmacologia , Melanoma Experimental/patologia , Neoplasias da Próstata/patologia , Neoplasias Testiculares/patologia , Animais , Western Blotting , Bovinos , Embrião de Mamíferos/enzimologia , Embrião de Mamíferos/patologia , Imunofluorescência , Glicosilação , Humanos , Solanum lycopersicum/enzimologia , Masculino , Camundongos , Camundongos Nus , RNA de Cadeia Dupla/genética , RNA de Cadeia Dupla/metabolismo , Proteínas Recombinantes/uso terapêutico , Taxa de Sobrevida , Células Tumorais Cultivadas
8.
Neoplasma ; 55(2): 127-9, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18237250

RESUMO

Photodynamic therapy (PDT) has been developed in recent years as a new modality for the treatment of various neoplastic and non-neoplastic lesions. Although the method of combining light with photosensitizers for treatment has been around for a century, further understanding has been evolved over the past decades. The method is based on the phenomenon involving the combination of photosensitizer and light. Neither drug nor light alone are effective as therapeutic agents. The antitumour effects result from direct cell damage, destruction of tumor vasculature and activation of a nonspecific immune response. The more accepted use of PDT is still restricted for ophthalmology, dermatology and treatment of some stages of esophageal, lung and urinary bladder cancer. In our experiments, the effect of phototherapy with disulfonated hydroxyaluminium phthalocyanine (Al(OH)S2Pc) and photofrin (control group) on the growth of human colorectal carcinoma on nude mice was studied. We chose colorectal carcinoma, because the Czech population has the highest incidence and it is still increasing. We try to offer a new possibility of treatment for patients with this severe disease.


Assuntos
Neoplasias Colorretais/tratamento farmacológico , Éter de Diematoporfirina/uso terapêutico , Indóis/uso terapêutico , Compostos Organometálicos/uso terapêutico , Fotoquimioterapia , Fármacos Fotossensibilizantes/uso terapêutico , Animais , Células HCT116 , Humanos , Camundongos
9.
Neoplasma ; 55(2): 158-64, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18237255

RESUMO

The antitumor effect of black pine (Pinus nigra) pollen nuclease (PN) tested in vitro was negligible in comparison with bovine seminal ribonuclease (BS-RNase). However, in the experiments in vivo a significant decrease of the human melanoma tumor size was observed in the mice treated with this nuclease and also with the animal RNases and DNase I. In nude mice injected intratumoraly with PN (10 microg/dose) the tumor size decreased from 100% in the control mice to 46% in treated mice whereas in counterparts treated with BS-RNase and DNase I the tumor growth was reduced a little more, however after ten times higher doses (100 and 80 microg per dose). Certain aspermatogenic and embryotoxic activity as an expression of side effects of PN and comparative enzymes also appeared, but it was lower compared to the effect of bovine seminal ribonuclease. Immunogenicity of PN was significantly weaker in comparison with BS-RNase. The antibodies against black pine nuclease produced in the injected mice did not inactivate the biological effects of this plant nuclease in vivo. In conclusion PN nuclease proved in vivo higher antitumor activity against human melanoma tumors growing in athymic mice in comparison with animal bovine seminal ribonuclease and DNase I.


Assuntos
Antineoplásicos Fitogênicos/farmacologia , Endonucleases/farmacologia , Pinus/enzimologia , Pólen/enzimologia , Animais , Linhagem Celular Tumoral , Desenvolvimento Embrionário/efeitos dos fármacos , Endonucleases/imunologia , Endonucleases/toxicidade , Endorribonucleases/farmacologia , Feminino , Humanos , Masculino , Camundongos , Camundongos Endogâmicos ICR , Espermatogênese/efeitos dos fármacos
10.
Physiol Res ; 56 Suppl 1: S1-S4, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17552901

RESUMO

A new generator of two successive shock waves focused to a common focal point has been developed. Cylindrical pressure waves created by multichannel electrical discharges on two cylindrical composite anodes are focused by a metallic parabolic reflector - cathode, and near the focus they are transformed to strong shock waves. Schlieren photos of the focal region have demonstrated that mutual interaction of the two waves results in generation of a large number of secondary short-wavelength shocks. Interaction of the focused shockwaves with liver tissues and cancer cell suspensions was investigated. Localized injury of rabbit liver induced by the shock waves was demonstrated by magnetic resonance imaging. Histological analysis of liver samples taken from the injured region revealed that the transition between the injured and the healthy tissues is sharp. Suspension of melanoma B16 cells was exposed and the number of the surviving cells rapidly decreased with increasing number of shocks and only 8 % of cells survived 350 shocks. Photographs of cells demonstrate that even small number of shocks results in perforation of cell membranes.


Assuntos
Membrana Celular/patologia , Fígado/patologia , Melanoma Experimental/patologia , Ultrassom/efeitos adversos , Animais , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos da radiação , Desenho de Equipamento , Fígado/lesões , Imageamento por Ressonância Magnética , Camundongos , Camundongos Endogâmicos C57BL , Necrose , Coelhos , Fatores de Tempo
11.
Physiol Res ; 56(4): 475-484, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-16925462

RESUMO

Proteinase-activated receptor-2 (PAR-2) is a ubiquitous surface molecule participating in many biological processes. It belongs to the family of G protein-coupled receptors activated by the site-specific proteolysis of trypsin and similar proteases. Altered function of PAR-2 has been described in different malignant tumors. In the present study, we investigated the expression of PAR-2 in breast cancer surgical specimens and the role of trypsin in breast cancer cell line MDA MB-231 proliferation and metabolism. A total of 40 surgical samples of infiltrative ductal breast cancer and breast cancer cell line were included in this study. We analyzed PAR-2 expression by immunohistochemistry, RT-PCR and western blot. Activation of PAR-2 on cell line MDA MB-231 was measured using calcium mobilization assay determined by flow cytometry. MTT cell metabolism assay and cell count analysis were used to assess the trypsin influence on breast cancer cell line MDA MB-231 proliferation. Immunohistochemical examination showed the expression of PAR-2 in all samples of breast cancer surgical specimens and high levels of cell lines which was confirmed by RT-PCR and western blot. Calcium mobilization assay corroborated the activation of PAR-2 on cell line MDA MB-231 either by trypsin or by an agonistic peptide. Cell metabolism assay and cell count analysis showed significant differences of proliferative activity of breast cancer cells dependent on the presence or absence of trypsin and serum in the culture medium. PAR-2 is expressed by high levels in infiltrative ductal breast cancer tissue specimens. PAR-2 is also strongly expressed in studied breast cancer cell lines. PAR-2 is activated by trypsin and also by agonistic peptide in the model of breast cancer cell line MDA MB-231. Activation of PAR-2 in vitro influences proliferative and metabolic activity of breast cancer cell line MDA MB-231. The action of trypsin is modified by the presence of serum which is a potential source of protease inhibitors.


Assuntos
Neoplasias da Mama/metabolismo , Sinalização do Cálcio , Carcinoma Ductal de Mama/metabolismo , Proliferação de Células , Receptor PAR-2/metabolismo , Tripsina/metabolismo , Western Blotting , Neoplasias da Mama/enzimologia , Neoplasias da Mama/genética , Neoplasias da Mama/patologia , Sinalização do Cálcio/efeitos dos fármacos , Carcinoma Ductal de Mama/enzimologia , Carcinoma Ductal de Mama/genética , Carcinoma Ductal de Mama/patologia , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Forma Celular , Feminino , Regulação Neoplásica da Expressão Gênica , Humanos , Imuno-Histoquímica , Estadiamento de Neoplasias , Oligopeptídeos/farmacologia , Receptor PAR-2/agonistas , Receptor PAR-2/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Fatores de Tempo
12.
Neoplasma ; 53(5): 402-9, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-17013534

RESUMO

Bovine seminal ribonuclease (BS RNase), a dimeric homolog of bovine pancreatic ribonuclease (RNase A), is known to display special biological activities namely cytotoxicity for human tumor cells. Because some plant ribonucleases have a similar mass weight and structure as the animal ribonuclease, effects of a commercial product of Mung bean (Phaseolus aureus) nuclease (PhA) were studied on proliferation of ML-2 human tumor cells, as well as it's aspermatogenic, embryotoxic, immunogenic, and immunosuppressive activity, and therapeutic efficiency in athymic mice bearing human melanoma tumor. Concerning the antiproliferative activity, PhA nuclease was almost non-effective in vitro on ML-2 cells and also immunosuppressive activity on human lymphocyte in mixed culture was very low compared to that of BS RNase. However, significant antitumor activity was detected on human melanoma tumor after intratumoral or intraperitoneal administration into the mice. Furthermore conjugate of PhA nuclease with polyethylene glycol (PEG) injected seven times at the dose of 10 microg intraperitoneally showed identical antitumor activity as that of bovine seminal ribonuclease (BS RNase) injected by the same way at ten times higher dose. Both PhA and BS RNases exerted strong aspermatogenic effect on the width of spermatogenic layers while RNase A administration at ten times higher concentration was ineffective. PhA nuclease when compared by means of antibody cross reaction with RNase A, BS RNase and wheat leaf neutral RNase (WLN-RNase) was found to be immunologically similar to RNase A and WLN-RNase, meanwhile BS RNase showed much higher antigenicity in comparison with them.


Assuntos
Neoplasias Experimentais/tratamento farmacológico , Phaseolus/enzimologia , Endonucleases Específicas para DNA e RNA de Cadeia Simples/imunologia , Endonucleases Específicas para DNA e RNA de Cadeia Simples/farmacologia , Animais , Antineoplásicos/farmacologia , Antiespermatogênicos/farmacologia , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Embrião de Mamíferos/efeitos dos fármacos , Humanos , Masculino , Camundongos , Camundongos Nus , Ribonuclease Pancreático/imunologia , Ribonuclease Pancreático/farmacologia , Espermatogênese/efeitos dos fármacos , Espermatozoides/efeitos dos fármacos , Teratogênicos/farmacologia
13.
Neoplasma ; 53(1): 79-85, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16416018

RESUMO

Previously we have shown that monomeric RNase A has no significant biological activity, whereas its oligomers (dimer to tetramer) prepared by lyophilizing from 50% acetic acid solutions, show remarkable aspermatogenic and antitumor activities. Furthermore, conjugates prepared by chemical binding of native RNase A to polyethylene glycol (PEG) have shown a significant aspermatogenic and antitumor activities. In this work we show that the chemical conjugation of PEG to the RNase A C-dimer, and to the two RNase A trimers (NC-trimer and C- trimer) decreases the aspermatogenic activity of the oligomers while increasing their inhibitory activity on the growth of the human UB900518 amelanotic melanoma transplanted in athymic nude mice. Moreover, the PEG-conjugated RNaseA oligomers are devoid, like the free oligomers, of any embryotoxic activity.


Assuntos
Antineoplásicos/farmacologia , Fragmentos de Peptídeos/farmacologia , Polietilenoglicóis/farmacologia , Ribonuclease Pancreático/farmacologia , Animais , Antineoplásicos/química , Antiespermatogênicos/farmacologia , Linhagem Celular Tumoral , Dimerização , Embrião de Mamíferos/efeitos dos fármacos , Humanos , Masculino , Melanoma Experimental/tratamento farmacológico , Camundongos , Transplante de Neoplasias , Fragmentos de Peptídeos/química , Polietilenoglicóis/química , Ribonuclease Pancreático/química , Espermatogênese/efeitos dos fármacos
14.
J Control Release ; 95(1): 83-92, 2004 Feb 20.
Artigo em Inglês | MEDLINE | ID: mdl-15013235

RESUMO

The hydrophilic poly[N-(2-hydroxypropyl)methacrylamide] (PHPMA) was used for RNase A or BS-RNase modification to prevent their degradation in bloodstream or fast elimination. Two PHPMA chains (classic and star-like) were synthesized and their conjugates with both enzymes were tested on the CD-1 nude mice bearing various human tumors. These RNase conjugates injected intravenously or intraperitoneally into the mice bearing melanoma, neuroblastoma or ovarian tumor caused significant reduction of transplanted tumors following ten daily doses of 2.5 and/or 1 mg/kg, respectively, while free RNase A or BS-RNase injected in doses of 10 mg/kg exerted only negligible antitumor activity. Histological examination confirmed potent cytotoxic effect of RNase A conjugates in ovarian tumor. Despite the antitumor activity observed in vivo, the in vitro cytotoxic activity of RNase A conjugates was not pronounced and did not differ from that caused by the free RNase A. The in vitro experiments with 125I-labeled preparations demonstrated that polymer conjugates were internalized by tumor cells very poorly in contrast to the dose-dependent internalization of the wild enzyme preparation. Surprisingly, mice injected with EL-4 leukemic cells, which were preincubated for 4 h with BS-RNase conjugates, exerted significantly prolonged survival compared with the control non-treated mice. It may be supposed that both BS-RNase and RNase A conjugates with PHPMA act after administration in vivo by a mechanism different from that or those occurring under in vitro conditions because in vivo they exert an antitumor action, whereas in vitro, they are ineffective. The experiments proved that RNase A, when conjugated to PHPMA, produced identical aspermatogenic and antitumor effects as BS-RNase conjugated to this polymer and that this preparation may be regarded as a potential anticancer drug.


Assuntos
Antineoplásicos , Antineoplásicos/administração & dosagem , Pâncreas/enzimologia , Ribonucleases/administração & dosagem , Ribonucleases/farmacologia , Sêmen/enzimologia , Animais , Antineoplásicos/imunologia , Bovinos , Divisão Celular/efeitos dos fármacos , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Injeções Intraperitoneais , Injeções Intravenosas , Metacrilatos , Camundongos , Camundongos Nus , Transplante de Neoplasias , Neuroblastoma/tratamento farmacológico , Neoplasias Ovarianas/tratamento farmacológico , Polímeros , Gravidez , Ribonuclease Pancreático/administração & dosagem , Ribonuclease Pancreático/imunologia , Ribonuclease Pancreático/farmacologia , Ribonucleases/imunologia , Espermatogênese/efeitos dos fármacos , Teratogênicos/farmacologia , Células Tumorais Cultivadas
15.
J Drug Target ; 10(3): 175-83, 2002 May.
Artigo em Inglês | MEDLINE | ID: mdl-12075818

RESUMO

Recently hydrophilic poly[N-(2-hydroxypropyl)methacrylamide] (PHPMA) was used for BS-RNase modification to prevent its degradation in bloodstream or fast elimination. Polymer-conjugated BS-RNase preparations proved to be cytotoxic after intravenous or intraperitoneal application, whereas native BS-RNase was ineffective. Here RNase A unimer was conjugated with two HPMA polymers (classic and star) and their antitumor effects both in vitro and in vivo were compared with those of BS-RNase polymers. Surprisingly, the antitumor effect of RNase A conjugates was also pronounced. The RNase A conjugates (classic and star) injected intravenously to mice bearing melanoma tumor caused a significant reduction in tumor volume following ten doses of 5 and 1 mg/kg, respectively. Despite the antitumor activity observed in vivo, the in vitro tested cytotoxic activity of RNase A did not differ from that caused by native RNase A while native BS-RNase (50 microg/ml) totally inhibited DNA synthesis in treated cells. The experiments with 125I-labeled preparations demonstrated concentration-dependent internalization of native BS-RNase by tumor cells within an hour, whereas the polymer conjugate (S-BS) was not internalized. On the contrary, the in vivo experiments showed that whereas 40% of S-BS conjugate persisted in bloodstream for 24h after administration, 98% of the native BS-RNase was already eliminated. Improved antitumor activities of PHPMA-modified RNases in vivo might be ascribed to their prolonged retention in bloodstream, better proteolytic stability and resistance to the action of the ribonuclease inhibitor.


Assuntos
Antineoplásicos/uso terapêutico , Endorribonucleases/uso terapêutico , Melanoma Experimental/tratamento farmacológico , Ácidos Polimetacrílicos/administração & dosagem , Ribonuclease Pancreático/uso terapêutico , Animais , Antineoplásicos/administração & dosagem , Antineoplásicos/química , Sítios de Ligação/fisiologia , Bovinos , Relação Dose-Resposta a Droga , Vias de Administração de Medicamentos , Portadores de Fármacos , Endorribonucleases/administração & dosagem , Endorribonucleases/química , Feminino , Humanos , Injeções Intraperitoneais , Injeções Intravenosas , Radioisótopos do Iodo , Linfócitos/metabolismo , Melanoma Experimental/patologia , Camundongos , Camundongos Nus , Estrutura Molecular , Ácidos Polimetacrílicos/química , Conformação Proteica , Ribonuclease Pancreático/administração & dosagem , Ribonuclease Pancreático/química , Células Tumorais Cultivadas/metabolismo , Ensaios Antitumorais Modelo de Xenoenxerto
16.
Int J Tissue React ; 24(3): 81-8, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12635860

RESUMO

Radiation damage results in blood-brain barrier damage followed by blood plasma transfer into the neuropil. The transferred liquid contains high amounts of biologically active substances/proteinases including factor Xa and a free pool of serum trypsin, which is not bound to antiproteases (alpha1 AT, alpha2-macroglobulin). The aim of this study was to follow up expression of proteinase-activated receptor-2 (PAR-2) in the brains of Wistar rats after single exposure to radiation at 26 Gy (60Co, 23 min, 15 sec). After irradiation, the animals were sacrificed on days 10, 20, 30 and 40. Control rat brains served as negative control. Coronal sections of caudal diencephalons were investigated using histology and immunohistochemistry. Polyclonal goat specified antibody against the NH-end of murine and rat PAR-2. Significant PAR-2 membrane positivity of scattered swollen neurons in deeper cortical layers was found in irradiated animals compared with controls. Although this membrane positivity was noticed in all irradiated animals, the most prominent occurred on day 30. Diffuse cytoplasmic positivity was also demonstrated on shrunken neurons in the cortex and hippocampus. Increased cytoplasmic and polarized membrane positivity was also noticed on the neurons of hypothalamic nuclei The causal relationship between blood-brain barrier damage, PAR-2 activation and neurodegeneration has not yet been verified. However, the present findings indicate that PAR-2 mediates a certain cellular response. It remains to be demonstrated whether this is a response to higher concentrations of factor Xa, a free pool of trypsin or other unknown possible proteinases in brain tissue; whether changes in PAR-2 expression are consequences of direct radiation damage to neuronal cells; whether this reaction is protective; and whether primary PAR-2 activation results in neuronal damage.


Assuntos
Neurônios/efeitos da radiação , Lesões Experimentais por Radiação/patologia , Receptores de Trombina/metabolismo , Telencéfalo/efeitos da radiação , Animais , Edema/etiologia , Edema/patologia , Técnica Indireta de Fluorescência para Anticorpo , Neurônios/metabolismo , Neurônios/patologia , RNA Mensageiro/metabolismo , Lesões Experimentais por Radiação/metabolismo , Ratos , Ratos Wistar , Receptor PAR-2 , Receptores de Trombina/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Telencéfalo/metabolismo , Telencéfalo/patologia
17.
Cancer Chemother Pharmacol ; 47 Suppl: S16-22, 2001 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-11561867

RESUMO

PURPOSE: The aim of the present study was to investigate the effect of a mixture of proteolytic enzymes (comprising trypsin, chymotrypsin and papain) on the metastatic model of syngeneic melanoma B16. METHODS: 140 C57B16 mice were divided into two control and two "treated" groups. Control groups received saline rectally, twice a day starting 24 h after intracutaneous transplantation (C1) or from the time point of the primary B16 melanoma extirpation (C2), respectively. "Treated" groups were rectally administered a mixture of 0.2 mg trypsin, 0.5 mg papain, and 0.2 mg chymotrypsin twice daily starting 24 h after transplantation (E1) or after extirpation of the tumor (E2), respectively. Survival of mice and B16 melanoma generalization were observed for a period of 100 days. Immunological evaluation of B16 melanoma cells in the ascites was accomplished. CD44, CD54 and CD106 cells were measured by flow cytometry. RESULTS: Administration of proteolytic enzymes to mice inhibited the growth of primary tumors, and tumor recurrences were less numerous. Importantly, metastasis was considerably curtailed both in the vicinity of the primary tumor and at distant locales. These findings correlated with a decreased expression of CD44 and CD54 molecules in tumors exposed to proteolytic enzymes in vivo. CONCLUSIONS: Our data suggest that serine and cysteine proteinases suppress B16 melanoma, and restrict its metastatic dissemination in C57B16 mice.


Assuntos
Antineoplásicos/farmacologia , Quimotripsina/farmacologia , Endopeptidases/farmacologia , Melanoma Experimental/tratamento farmacológico , Papaína/farmacologia , Tripsina/farmacologia , Administração Retal , Animais , Antígenos de Superfície/imunologia , Divisão Celular/efeitos dos fármacos , Quimotripsina/administração & dosagem , Combinação de Medicamentos , Feminino , Receptores de Hialuronatos/imunologia , Imunoglobulinas/imunologia , Molécula 1 de Adesão Intercelular/imunologia , Neoplasias Pulmonares/imunologia , Neoplasias Pulmonares/prevenção & controle , Neoplasias Pulmonares/secundário , Melanoma Experimental/imunologia , Melanoma Experimental/patologia , Melanoma Experimental/secundário , Camundongos , Camundongos Endogâmicos C57BL , Papaína/administração & dosagem , Tripsina/administração & dosagem
18.
Neoplasma ; 48(2): 127-32, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11478693

RESUMO

Bovine seminal ribonuclease (BS-RNase) exerts a potent cytotoxic activity when administered intratumorally (i.t.) to the nude mice bearing human tumors. The ineffective treatment with intravenous (i.v.) or intraperitoneal (i.p.) administration led us to the synthesis of polymeric conjugates with BS-RNase to prevent it from degradation in the blood vessel. Hydrophilic poly[N-(2-hydroxypropyl)methacrylamide] (PHPMA) was used for BS-RNase modification and a PHPMA-BS-RNase conjugates were prepared. Classic conjugate (P-BS) with BS-RNase bound to the polymer by its oligopeptide site chains was prepared by aminolytic reaction of the polymer precursor bearing reactive ester groups situated in the side chains of polymer, while star-like conjugate (S-BS) was synthesized by the reaction of PHPMA containing end-chain reactive group with BS-RNase in aqueous buffer solution at pH 8. In contrast to the total ineffectiveness of free BS-RNase administered i.v. at a daily dose 10 mg/kg, application of P-BS and S-BS conjugates at doses 2 mg/kg and 0.5 mg/kg caused significant inhibition of the growth of human melanoma in nude mice. On the base of these results the effect of i.v. administered S-BS on the metastatic process and the survival of C57Bl/6 inbred mice inoculated with B16 melanoma cells was investigated. Sixty per cent of mice treated with S-BS (0.5 mg/kg/day) survived 100 days without metastatic foci when the experiment terminated. The average survival time of the treated groups was 75.5 days compared to 32.7 days in the control group. BS-RNase conjugated to water soluble polymers appears to be the first BS RNase preparation which exerts anticancer and antimetastatic activity following its intravenous administration.


Assuntos
Antineoplásicos/uso terapêutico , Endorribonucleases/uso terapêutico , Melanoma Experimental/tratamento farmacológico , Melanoma/tratamento farmacológico , Melanoma/secundário , Metástase Neoplásica/prevenção & controle , Animais , Antineoplásicos/administração & dosagem , Antineoplásicos/toxicidade , Bovinos , Relação Dose-Resposta a Droga , Portadores de Fármacos , Endorribonucleases/administração & dosagem , Endorribonucleases/toxicidade , Feminino , Humanos , Injeções Intraperitoneais , Injeções Intravenosas , Melanoma/patologia , Melanoma Experimental/patologia , Melanoma Experimental/secundário , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Nus , Ácidos Polimetacrílicos
19.
Anticancer Drugs ; 12(5): 467-73, 2001 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-11395575

RESUMO

Treatment failure in most neuroblastoma (NB) patients is related to primary and/or acquired resistance to conventional chemotherapeutic agents. Aphidicolin (APH), a tetracyclic diterpene, exhibits specific cytotoxic action against NB cells. The purpose of this study was to compare antitumoral efficacy of APH in parental NB cell lines and cell subclones that exhibit drug resistance to vincristine (VCR), doxorubicin (DOX) and cisplatin. Due to poor solubility of APH in water, gamma-cyclodextrin (gamma-CD) inclusion complexes of APH were used for systemic treatment of xenotransplanted parental and VCR-resistant UKF-NB-3 tumours. APH and its gamma-CD inclusion complexes inhibited growth of parental and drug-resistant NB cells at equimolar doses in vitro. Growth of VCR-sensitive and -resistant NB tumors was inhibited at equal doses in a dose-dependent fashion in vivo. These results indicate that the specific cytotoxic activity of APH against NB cells in vitro and in vivo is independent of cellular mechanisms facilitating drug resistance to conventional chemotherapeutic drugs. Hence, taking into account our previous findings that APH acts synergistically with VCR and DOX, APH might be an additive tool for the therapy of NB and is suitable for evaluation in clinical studies of NB treatment protocols.


Assuntos
Afidicolina/uso terapêutico , Sobrevivência Celular/efeitos dos fármacos , Ciclodextrinas/farmacologia , Inibidores Enzimáticos/uso terapêutico , Neuroblastoma/tratamento farmacológico , Células Tumorais Cultivadas/efeitos dos fármacos , Animais , Antineoplásicos/uso terapêutico , Afidicolina/análogos & derivados , Peso Corporal/efeitos dos fármacos , Portadores de Fármacos , Resistencia a Medicamentos Antineoplásicos , Feminino , Humanos , Camundongos , Camundongos Nus , Neuroblastoma/patologia , Células Tumorais Cultivadas/patologia
20.
Anticancer Res ; 21(2A): 1035-42, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11396137

RESUMO

BACKGROUND: Anaplastic thyroid carcinoma is an aggressive solid tumor that fails to adequately respond to any known chemotherapeutic regimen. The development of effective chemotherapy agents would provide the best chance for long-term survival of patients. MATERIALS AND METHODS: The cytotoxic effects of bovine seminal ribonuclease (BS-RNase) against thyroid carcinoma cell lines with different degrees of differentiation in comparison to non-malignant cells, including human foreskin fibroblasts (HFF) and retinal pigment epithelial cells (RPE), were tested using the MTT dye reduction assay. Induction of apoptosis was demonstrated by annexin V assay and expression of proteins related to apoptosis was investigated by flow cytometry. The antitumoral in vivo effects of BS-RNase were assessed on established xenografts of anaplastic thyroid carcinoma cell line 8505C in nude mice using subcutaneous injections of BS-RNase (12.5 mg/kg once a day, on 20 consecutive days). RESULTS: All the tumor cell lines exhibited marked sensitivity against BS-RNase in comparison to HFF and RPE cells. The greatest growth inhibition was seen in the 8505C line, while IC50 values for papillary (B-CPAP) and poorly-differentiated thyroid carcinoma cells were about 6-fold higher. The cytotoxic action of BS-RNase was associated with induction of apoptosis. Expressions of Fas and Fas-ligand were not influenced by BS-RNase completely, while the down-regulation of Bcl-2 in treated cells was observed. In vivo treatment induced significant tumor regression after the course of 20 consecutive days. No apparent toxic effects of BS-RNase toward non-malignant cells were observed during the in vivo treatment. After cessation of therapy (day 20) tumor volume continued to decrease and the tumor was no longer detectable after 30 days of treatment induction in all animals. CONCLUSION: BS-RNase may have beneficial effects for treatment of aggressive anaplastic thyroid cancer.


Assuntos
Antineoplásicos/uso terapêutico , Endorribonucleases/uso terapêutico , Neoplasias da Glândula Tireoide/tratamento farmacológico , Animais , Antineoplásicos/farmacologia , Apoptose , Bovinos , Endorribonucleases/farmacologia , Proteína Ligante Fas , Feminino , Humanos , Glicoproteínas de Membrana/biossíntese , Camundongos , Camundongos Nus , Transplante de Neoplasias , Neoplasias Experimentais , Proteínas Proto-Oncogênicas c-bcl-2/biossíntese , Neoplasias da Glândula Tireoide/patologia , Células Tumorais Cultivadas , Receptor fas/biossíntese
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...